Statins are well tolerated by most patients, but in some cases can produce a variety of relevant adverse effects mostly muscle associated. Among them, one recently emerging risk, which is the topic of this review article, is the increased incidence of new-onset insulin resistance and type 2 diabetes mellitus (T2DM) in association with statin treatment [2].